In a groundbreaking move to enhance research, improve healthcare, and pioneer vaccine development for diseases that disproportionately affect Nigeria and Africa, the University of Nigeria, Nsukka, Enugu State, has launched the inaugural Vaccine Research Centre.

This state-of-the-art facility, made possible through funding from the United States National Health Institute and the Bill and Belinda Gates Foundation, was officially inaugurated on Tuesday.

According to the UNN Vice Chancellor, Prof Charles Igwe, the establishment of the centre marks a significant milestone, particularly given the challenges posed by the COVID-19 pandemic and prolonged strikes by the Academic Staff Union of Universities.

He commended the tireless efforts of Prof Silva Anika and his team in bringing the project to fruition and pledged to ensure the centre makes a substantial impact in addressing tropical diseases affecting both humans and animals in Nigeria.

The Director of the VRC, Prof Anika, outlined the centre’s multifaceted role in training, research, and vaccine production for various endemic tropical diseases, emphasizing the importance of forging collaborative partnerships with national and international entities to ensure the centre’s sustainability and global influence.

He also highlighted an ongoing research initiative focused on diseases such as African Trypanosomiasis (sleeping sickness), which causes considerable human suffering and economic losses.

Prof Anika expressed confidence in translating the research findings into practical programmes that will save lives, enhance livestock health, and boost productivity.

However, he noted the challenge posed by the need for a consistent power supply to operate the centre’s cutting-edge equipment, valued at approximately $1 million USD.